L. Hofer

Most-cited papers

1. Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity

   Rouven Hoefflin, B. Lahrmann, Gregor Warsow, D. Hübschmann +25 more

   2016Nature Communications63 citations Open access

   Semantic Scholar

   Save

2. Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort

   S. Zschäbitz, N. Biernath, T. Hilser, Alexander Höllein +22 more

   2023European Urology Open Science49 citations Open access

   Semantic Scholar

   Save

3. Retzius-sparing robot-assisted laparoscopic radical prostatectomy: functional and early oncologic results in aggressive and locally advanced prostate cancer

   J. Nyarangi-Dix, M. Görtz, Georgi Gradinarov, L. Hofer +4 more

   2019BMC Urology35 citations Open access

   Semantic Scholar

   Save

4. High prevalence of DNA damage repair gene defects and TP53 alterations in men with treatment-naïve metastatic prostate cancer -Results from a prospective pilot study using a 37 gene panel.

   Cathleen Nientiedt, V. Endris, M. Jenzer, J. Mansour +41 more

   2020Urologic oncology25 citations Open access

   Semantic Scholar

   Save

5. Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer.

   Cathleen Nientiedt, J. Budczies, V. Endris, M. Kirchner +35 more

   2021Urologic oncology23 citations Open access

   Semantic Scholar

   Save

6. Predicting the Risk of Metastases by PSMA-PET/CT—Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma

   S. Koerber, Johannes Boesch, C. Kratochwil, I. Schlampp +12 more

   2021Cancers16 citations Open access

   Semantic Scholar

   Save

7. Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery

   Viktoria Schütz, P. Reimold, Magdalena Goertz, L. Hofer +5 more

   2021Journal of Clinical Medicine14 citations Open access

   Semantic Scholar

   Save

8. Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL

   S. Dieffenbacher, S. Zschäbitz, L. Hofer, G. Hatiboglu +6 more

   2018Future Science OA9 citations Open access

   Semantic Scholar

   Save

9. Re: Radical Prostatectomy or Watchful Waiting in Prostate Cancer-29-Year Follow-up.

   L. Hofer, M. Hohenfellner

   2019European Urology2 citations

   Semantic Scholar

   Save

10. [Level IV inferior vena cava tumor thrombus : A rare diagnosis in patients with renal cell carcinoma].

    L. Hofer, C. Gasch, G. Hatiboglu, J. Motsch +3 more

    2017Der Urologe (Ausg. A)2 citations

    Semantic Scholar

    Save

11. Rezidivfreies Überleben nach radikaler Prostatektomie und PDE-5-Hemmer-Einnahme

    L. Hofer, J. Radtke, C. Rapp, S. Pahernik +3 more

    2016Der Urologe2 citations

    Semantic Scholar

    Save

12. MP15-14 RETZIUS-SPARING (rsRARP) vs. CONVENTIONAL ROBOTIC ASSISTED RADICAL PROSTATECTOMY (cRARP)—A PROSPECTIVE, RANDOMISED, SINGLE BLINDED TRIAL—RESULTS OF EARLY CONTINENCE

    J. Nyarangi-Dix, Viktoria Schuetz, Maximilian Guettlein, David Wuerkner +7 more

    20210 citations

    Semantic Scholar

    Save

13. Retzius-sparing vs. conventional robotic assisted radical prostatectomy in a prospective, randomised trial – early functional outcome and quality of life

    V. Schütz, M. Güttlein, D. Würkner, L. Hofer +6 more

    2021European Urology0 citations

    Semantic Scholar

    Save

14. Level-IV-Cavathrombus

    L. Hofer, Claudia Gasch, G. Hatiboglu, J. Motsch +3 more

    2017Der Urologe0 citations

    Semantic Scholar

    Save